Small sample sizes used in previous studies result in a lack of overlap between the reported gene signatures for prediction of chemotherapy response. Although morphologic features, especially tumor nuclear morphology, are important for cancer grading, little research has been reported on quantitatively correlating cellular morphology with chemotherapy response, especially in a large data set. In this study, we have used a large population of patients to identify molecular and morphologic signatures associated with chemotherapy response in serous ovarian carcinoma.<0.0001). In parallel, we present the production of a tumor nuclear image profile generated from 253 sample slides by characterizing patients with nuclear features (such as size, e...
Standard treatment of patients with advanced stage ovarian cancer is surgical debulking followed by ...
We investigated whether prognostic information is reflected in the expression patterns of ovarian ca...
Seventy percent of ovarian cancer patients die due to consecutive episodes of recurrences resulting ...
Small sample sizes used in previous studies result in a lack of overlap between the reported gene si...
Background: Small sample sizes used in previous studies result in a lack of overlap between the repo...
<div><h3>Background</h3><p>Small sample sizes used in previous studies result in a lack of overlap b...
AbstractArray comparative genomic hybridization (aCGH) and microarray expression profiling were used...
The majority of patients with high-grade serous ovarian cancer (HGSOC) initially respond to chemothe...
Tering of OC spheroids following treatment with all used drugs (cisplatin, topotecan and paclitaxel ...
Background Chemotherapy resistance remains a major obstacle in the treatment of women with ovarian c...
Background Chemotherapy resistance remains a major obstacle in the treatment of women with ovarian c...
<p>(A) Identification of gene signature differentially expressed in chemoresistant and chemosensitiv...
We investigated whether prognostic information is reflected in the expression patterns of ovarian ca...
Objective: Transcriptional profiling of epithelial ovarian cancer has revealed molecular subtypes co...
We investigated whether prognostic information is reflected in the expression patterns of ovarian ca...
Standard treatment of patients with advanced stage ovarian cancer is surgical debulking followed by ...
We investigated whether prognostic information is reflected in the expression patterns of ovarian ca...
Seventy percent of ovarian cancer patients die due to consecutive episodes of recurrences resulting ...
Small sample sizes used in previous studies result in a lack of overlap between the reported gene si...
Background: Small sample sizes used in previous studies result in a lack of overlap between the repo...
<div><h3>Background</h3><p>Small sample sizes used in previous studies result in a lack of overlap b...
AbstractArray comparative genomic hybridization (aCGH) and microarray expression profiling were used...
The majority of patients with high-grade serous ovarian cancer (HGSOC) initially respond to chemothe...
Tering of OC spheroids following treatment with all used drugs (cisplatin, topotecan and paclitaxel ...
Background Chemotherapy resistance remains a major obstacle in the treatment of women with ovarian c...
Background Chemotherapy resistance remains a major obstacle in the treatment of women with ovarian c...
<p>(A) Identification of gene signature differentially expressed in chemoresistant and chemosensitiv...
We investigated whether prognostic information is reflected in the expression patterns of ovarian ca...
Objective: Transcriptional profiling of epithelial ovarian cancer has revealed molecular subtypes co...
We investigated whether prognostic information is reflected in the expression patterns of ovarian ca...
Standard treatment of patients with advanced stage ovarian cancer is surgical debulking followed by ...
We investigated whether prognostic information is reflected in the expression patterns of ovarian ca...
Seventy percent of ovarian cancer patients die due to consecutive episodes of recurrences resulting ...